Loading...
Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China
BACKGROUND: There is a paucity of large‐scale studies evaluating the clinical benefit of the Gaviscon Double Action (DA) alginate‐antacid formulation for treating gastroesophageal reflux disease (GERD) symptoms. AIM: Randomised double‐blind placebo‐controlled parallel‐group study to evaluate efficac...
Na minha lista:
| Udgivet i: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042071/ https://ncbi.nlm.nih.gov/pubmed/26228097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13334 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|